top of page

William Blair Senior Biotech Analyst Andy Hsieh joins Analyst Thursdays from the Bay Area

Andy Hsieh comments on AbbVie's buyout of ImmunoGen, gives a deep dive into the radiopharmaceutical space, and discusses AASLD data, the Seagen FTC review, and upcoming RSV data from Icosavax.



コメント


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page